Navigation Links
Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring
Date:10/21/2009

PHILADELPHIA, Oct. 21 /PRNewswire/ -- Sanovia, a leading provider of pharmacy utilization management solutions, today announced that it has been selected by HealthSpring, Inc. to deliver its PA-Logic(TM) pharmaceutical prior authorization platform to HealthSpring, one of the largest Medicare Advantage coordinated care plans in the U.S. The selection reinforces Sanovia's leadership in delivering pharmaceutical prior authorization solutions that help its customers drive down administrative costs and drug spend by automating the prior authorization process for high cost pharmaceuticals including specialty drugs and injectibles.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091021/PH95805LOGO )

HealthSpring will deploy Sanovia's web based PA-Logic(TM) to automate the prior authorizations for its Medicare Advantage and standalone prescription drug plan members. By automating a traditionally manual process, HealthSpring will more efficiently manage their pharmaceutical prior authorization process. The improvements brought by PA-Logic(TM)'s automated clinical pathways mean a marked improvement in processing turn-around time, consistency of decision making, and quality of the decisions being rendered. PA-Logic(TM) gives HealthSpring a comprehensive solution automating the entire pharmaceutical prior authorization process, from initial request to decision. Ultimately, PA-Logic(TM) will allow HealthSpring to ensure that its members are receiving the right drug, at the right time and at the right dose, while significantly reducing turn-around time and cost, and improving quality.

"We are delighted to count HealthSpring among our growing list of customers. HealthSpring's selection of our PA-Logic(TM) pharmaceutical management product demonstrates their recognition that Sanovia's products will help them to continue to deliver on their goal of healthier members with lower medical costs," said Robert E. Tremain, President and CEO of Sanovia.

About PA-Logic(TM)

Sanovia's PA-Logic(TM) is a web based solution that automates the pharmaceutical prior authorization process. PA-Logic(TM) uses best-practice clinical guidelines to evaluate pharmaceutical requests, ensure adherence to benefit designs and enable appropriate decisions when requests are made. By combining automation with clinical best practices, PA-Logic(TM) gives its healthplan and Pharmacy Benefit Manager (PBM) customers greater control and consistency in decision making, while driving down administrative costs and drug spend. The system manages and automates the pharmacy review process on an electronic platform, which reduces slow and error-prone paper-based methods, speeds routing of information and accelerates decisions to help prevent treatment delays. Plans can also allow their participating providers to access the system from their offices via the Internet, and submit requests electronically, thus eliminating the frustration of dealing with paper forms, phone calls, faxes and returns for incomplete information. PA-Logic(TM)'s letter writer and report generator functions automate workflow, produce real-time reports on pharmacy program operations and facilitate communications with patients and physicians.

About Sanovia Corporation

Sanovia is a leading provider of pharmacy utilization management solutions. Sanovia integrates smart business practices with automated decision-making technology and best-practice clinical guidelines, delivering proven savings in administrative costs and pharmaceutical spending for managed care companies and PBM's.

Sanovia's portfolio of innovative products and services meet the increasing challenges of pharmaceutical administration, validation, documentation, utilization, cost and workflow management. Clients use Sanovia's "intelligent" clinical decision support products to balance pharmaceutical cost management with appropriateness of therapy and quality of care. Sanovia is privately held and venture-backed, with no ownership by any pharmacy benefit manager, health plan or pharmaceutical manufacturer. Headquartered in Philadelphia, Sanovia can be reached at 610-521-2211 or at Sanovia.com.

SOURCE Sanovia Corporation


'/>"/>
SOURCE Sanovia Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. A Unique Endoluminal Approach for the Treatment of Morbid Obesity Selected for Presentation at the 2009 American College of Surgeons Clinical Congress
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
4. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
5. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
6. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
9. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
10. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
11. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
Breaking Medicine News(10 mins):